.The FDA has positioned Kezar Life Sciences' lupus trial on hold after the biotech flagged four fata...
.A phase 3 test of Scholar Stone's spine muscle atrophy (SMA) prospect has actually hit its key endp...
.RNA biotech CAMP4 Therapies has marked out think about a $67 thousand IPO, along with inflammation-...
.A year after the failing of an idiopathic lung fibrosis applicant delivered Galecto on a seek salva...
.Taking the mat is Judo Bio, an ambitious biotech equipped with $one hundred million to develop olig...
.AstraZeneca has settled CSPC Pharmaceutical Team $one hundred thousand for a preclinical heart atta...
.Zephyrm Bioscience is gusting toward the Hong Kong stock market, filing (PDF) for an IPO to money p...
.Frazier Lifespan Sciences has sourced an even further $630 thousand for its fund focused on tiny an...
.Antibody fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up its tec...
.Septerna is about to find out exactly how a biotech without "any kind of meaningful professional re...